BELLISAI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 3.470
EU - Europa 2.407
AS - Asia 355
OC - Oceania 8
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.246
Nazione #
US - Stati Uniti d'America 3.463
GB - Regno Unito 658
IE - Irlanda 539
SE - Svezia 340
CN - Cina 306
UA - Ucraina 261
DE - Germania 172
FR - Francia 153
IT - Italia 151
FI - Finlandia 78
ES - Italia 17
VN - Vietnam 14
IN - India 11
BE - Belgio 9
AU - Australia 7
IR - Iran 7
CA - Canada 5
RU - Federazione Russa 5
CZ - Repubblica Ceca 4
NL - Olanda 4
TR - Turchia 4
AT - Austria 3
BR - Brasile 3
JP - Giappone 3
CU - Cuba 2
EE - Estonia 2
EU - Europa 2
IM - Isola di Man 2
IQ - Iraq 2
PL - Polonia 2
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 6.246
Città #
Menlo Park 806
Southend 608
Dublin 530
Fairfield 366
Chandler 295
Ashburn 274
Jacksonville 205
Woodbridge 181
Wilmington 139
Houston 132
Seattle 132
Ann Arbor 118
Cambridge 112
Princeton 101
Nanjing 74
Beijing 70
Siena 46
New York 44
San Mateo 38
Boardman 37
Helsinki 36
Dearborn 35
Nanchang 25
San Diego 25
Shanghai 17
Málaga 16
Dong Ket 14
Hebei 14
Shenyang 14
Venezia 14
Washington 14
Changsha 11
Düsseldorf 11
Tianjin 11
Florence 10
London 10
Brussels 9
Jinan 9
Ningbo 9
Fremont 7
Guangzhou 7
Norwalk 7
Jiaxing 6
Kunming 6
Mestre 6
Rome 6
San Francisco 6
Chicago 5
Hanover 5
Naples 5
Milan 4
Olomouc 4
Redwood City 4
Brisbane 3
Como 3
Hefei 3
Izmir 3
Lanzhou 3
Leawood 3
Prescot 3
Vienna 3
Zanjan 3
Zhengzhou 3
Bangalore 2
Catania 2
Chengdu 2
Chiswick 2
Frankfurt am Main 2
Fuzhou 2
Hangzhou 2
Kashan 2
Kilburn 2
La Habana 2
Lancaster 2
Lappeenranta 2
Los Angeles 2
Melbourne 2
Mission Viejo 2
Pescara 2
Philadelphia 2
Saint Petersburg 2
Somma Vesuviana 2
São Paulo 2
Tokyo 2
Toronto 2
Treviso 2
Tukwila 2
Warsaw 2
Acton 1
Adelaide 1
Amsterdam 1
Anaheim 1
Andover 1
Ardabil 1
Arezzo 1
Asunción 1
Auburn Hills 1
Baghdad 1
Barletta 1
Bengaluru 1
Totale 4.782
Nome #
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 196
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 187
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus 177
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection 169
Anti-cofactor autoantibodies in systemic lupus erythematosus: prevalence, clinical and HLA class II associations 169
Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis 164
Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection 161
Cyclosporine A for the treatment of autoimmune disorders in HCV infected patients 160
Absence of anti-cyclic citrullinated peptide antibodies in erosive osteoarthritis: further serological evidence of the disease as a subset of osteoarthritis 159
Relationship between serum comp levels and serological markers of disease activity in rheumatoid arthritis patients treated with anti-tnf drugs. A study of the best way to manage indicators of response to therapy 154
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 152
Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments 147
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 145
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 143
Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension 141
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis 140
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 139
Chromosomal abnormalities in peripheral lymphocytes from idiopathic Raynaud's phenomenon patients 139
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 138
Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin 133
Anticardiolipin and antibeta2GPI antibodies In a large series of european patients with systemic lupus erythematosus: prevalence and clinical association 131
HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus 127
Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome 126
Prevalence of anti-Histone antibodies, their clinical significante and correlation with other autoantibodies in a color of italian scleroderma patients 123
Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis 121
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 118
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 117
Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders 115
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 100
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon 99
null 99
Chromosome aberrations in Raynaud's phenomenon 99
Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients 98
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicenter prospective study of 1000 patients. 95
Treatment strategies for apatient with rheumatoid arthritis and hepatitis C 93
Simultaneouspulmonary involvement, histologically proven, of sarcoidosis and rheumatoidarthritis. 92
La tipizzazione genetica nelle malattie reumatiche autoimmuni e nelle sindromi autoinflammatorie 92
Coexistence of the antiphospholipid syndrome and abdominal aortic aneurysm 91
HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with SLE 90
Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection 89
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 89
HCV e malattie autoimmuni 88
Combination therapy with cyclosporine A and anti-TNF-alpha agents in the treatment of rheumatoid arthritis and concomitant hepatitis C virus infection 87
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 83
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 83
Interstitial lung disease associated with psoriatic arthritis: a new disease entity? 82
Associazione interferon α2b e ciclosporina A nel trattamento dell'epatite cronica C: Trial controllato 74
Exploring the crosstalk between hydrostatic pressure and adipokines: an in vitro study on human osteoarthritic chondrocytes 72
Anterior chest wall non-traumatic diseases: A road map for the radiologist 65
Le indicazioni al trattamento con immunoglobuline endovena nella sindrome da anticorpi antifosfolipidi. [Indications for intra-venous immunoglobulins treatment in the antiphospholipid syndrome] 63
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 62
Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis 57
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 55
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 35
Peripheral Macrovascular Involvement in Systemic Sclerosis: A Cohort Study by Color and Spectral Doppler Ultrasonography 27
Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study 24
Clinical, laboratory and ultrasonographic findings at baseline predict long-term outcome of polymyalgia rheumatica: a multicentric retrospective study : Polymyalgia rheumatica predicted by ultrasonographic findings polymyalgia rheumatica outcome predicted early by ultrasound 21
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. 17
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 2
Totale 6.314
Categoria #
all - tutte 19.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019115 0 0 0 0 0 0 0 0 0 0 0 115
2019/20201.066 133 37 76 168 60 82 83 144 73 96 40 74
2020/2021853 51 79 23 72 46 134 28 131 110 44 65 70
2021/2022713 48 83 46 81 27 17 32 20 31 68 90 170
2022/20231.088 69 107 156 151 107 219 14 88 108 21 28 20
2023/2024793 37 15 78 78 28 233 280 9 2 10 10 13
Totale 6.314